The American journal of managed care
-
Medical engineers continue to develop and enhance continuous glucose monitoring (CGM) devices and other devices to improve care for persons with diabetes. In a remarkably short period of time, these devices have become refined. ⋯ Clinicians' knowledge and understanding of how to interpret the Ambulatory Glucose Profile (AGP) report can improve patient outcomes. In addition, organizations that recognize areas of workflow that may be impacted can implement processes that improve use of the standard AGP report.
-
The prevalence of diabetes is growing in the United States at an alarming rate. Early and intensive diagnosis and management of diabetes can reduce the economic burden and improve the societal burden of long-term diabetes-related complications. Healthcare providers practicing in the primary care setting are on the front line of screening, diagnosis, and managing a large majority of persons with diabetes. ⋯ Patients who utilize CGM are able to reduce their risk of hospitalizations, minimize work absenteeism, lower their A1C, lower their risk of hypoglycemia, as well as long-term microvascular and macrovascular complications. The American Diabetes Association updated its evidence-based Standards of Medical Care in Diabetes in 2022 around the use of CGM, as has the American Association of Clinical Endocrinology. Because these devices can have a positive effect on the management of persons with diabetes, managed care and healthcare providers should allow technological integration for their patients.